NHLBI and NIAID: Personalized Medicine Approaches Developed from NIH Asthma Clinical Trials
Friday, March 3, 2017: 10:00 AM-12:30 PM
Georgia World Congress Center, Building B, Level 5, Thomas B. Murphy Ballroom 1
2.50 CME/CE
Christine A. Sorkness , PharmD

Learning Objectives:
  1. Discuss clinical trial designs that have identified predictive biomarkers for asthma medications
  2. Discuss methods to identify prognostic predictors for asthma exacerbations with the goal of developing strategies to prevent them and to define the potential challenges of interpreting data for subpopulations in a clinical trial
  3. Identify procedures, such as the microbiome analysis, that may vary in findings based on the age of the study participant
10:00 AM
Use of the Cross-Over Clinical Trial Design to Identify Predictive Biomarkers for Asthma Medications
David M. Mauger, PhD
10:20 AM
Question & Answer
10:30 AM
Clinical Trial Designs to Predict Asthma Exacerbations
Agustin Calatroni, MA MS
10:50 AM
Question & Answer
11:00 AM
Assessing the Response of Subpopulations Within Clinical Trials to Evaluate Therapeutic Interventions
Michael E. Wechsler, MD
11:20 AM
Question & Answer
11:30 AM
The Relevance of Age in Clinical Trials to Study the Microbiome
Yvonne Huang, MD
11:50 AM
Question & Answer
12:00 PM
Panel Discussion
See more of: Session